MOLECULAR DOCKING EVALUATION OF CURCUMIN, URSOLIC ACID, QUERCETIN, BERBERINE, AND ANDROGRAPHOLIDE AGAINST HIV-1 REVERSE TRANSCRIPTASE AND PROTEASE
Background: HIV-1 reverse transcriptase (RT) and protease (PR) are primary targets for antiretroviral therapy. Natural phytochemicals from medicinal plants offer diverse chemical scaffolds for inhibiting these enzymes. This study evaluated the binding potential of curcumin, ursolic acid, quercetin, berberine, and andrographolide against HIV-1 RT and PR using molecular docking.
Methods: Molecular docking was performed against HIV-1 RT (PDB: 1REV) and HIV-1 protease (PDB: 1EBY) using AutoDockVina. Binding affinities, hydrogen bonding patterns, hydrophobic interactions, and π-π stacking were analyzed. Binding poses were visualized using Discovery Studio. ADMET properties were predicted using SwissADME.
Results: Curcumin demonstrated the highest binding affinity against RT (-11.5 kcal/mol) forming four hydrogen bonds with Lys101, Tyr181, Tyr188, and Asp185. Ursolic acid showed the highest binding against protease (-10.8 kcal/mol) with hydrophobic contacts to Asp25, Asp29, Ile50, and Ile84. Quercetin showed multi-target activity with -10.2 kcal/mol against integrase (from previous study) and -9.5 kcal/mol against RT. Berberine showed -9.3 kcal/mol against RT with electrostatic interactions. Andrographolide showed -8.5 kcal/mol against gp120. All compounds exhibited low toxicity and favorable drug-likeness.
Conclusion: Curcumin is the most potent RT inhibitor. Ursolic acid is the most potent protease inhibitor. Quercetin shows promising multi-target activity. These findings warrant in vitro validation through enzymatic inhibition assays.
Keywords: HIV-1 reverse transcriptase, HIV-1 protease, curcumin, ursolic acid, quercetin, molecular docking
Khatoon, A. (2026). Molecular Docking Evaluation of Curcumin, Ursolic Acid, Quercetin, Berberine, and Andrographolide Against HIV-1 Reverse Transcriptase and Protease. International Journal of Science, Strategic Management and Technology, 02(05). https://doi.org/10.55041/ijsmt.v2i5.445
Khatoon, Afsana. "Molecular Docking Evaluation of Curcumin, Ursolic Acid, Quercetin, Berberine, and Andrographolide Against HIV-1 Reverse Transcriptase and Protease." International Journal of Science, Strategic Management and Technology, vol. 02, no. 05, 2026, pp. . doi:https://doi.org/10.55041/ijsmt.v2i5.445.
Khatoon, Afsana. "Molecular Docking Evaluation of Curcumin, Ursolic Acid, Quercetin, Berberine, and Andrographolide Against HIV-1 Reverse Transcriptase and Protease." International Journal of Science, Strategic Management and Technology 02, no. 05 (2026). https://doi.org/https://doi.org/10.55041/ijsmt.v2i5.445.
2.Esmaeili, S., Mosaddeghi, H., &Ravari, F. (2021). Molecular Docking Studies of HIV-1 Protease-, Integrase- and Reverse-Transcriptase with Delta-9-tetrahydrocannabinol and Curcumin as Two Herbal Ligands. Journal of Surface Investigation, 57(2), 281-288.
3.Feng, L., Lu, W.H., Li, Q.Y., et al. (2023). Curcuma Longa Induces the Transcription Factor FOXP3 to Downregulate Human Chemokine CCR5 Expression and Inhibit HIV-1 Infection. American Journal of Chinese Medicine, 51(5), 1189-1209.
4.Jamwal, R. (2023). Bioavailability enhancement strategies for curcumin: A comprehensive review. Drug Delivery and Translational Research, 13(2), 345-362.
5.Kabir, O.O., Abdulfatai, T.A., & Akeem, A.J. (2015). Molecular Docking of HIV-1 env gp120 Using Diterpene Lactones from Andrographispaniculata. Organic Chemistry Current Research, 4(2), 1-7.
6.Maiti, P., Paladugu, L., & Dunbar, G.L. (2024). Blood-brain barrier permeability of curcumin: Implications for neurodegenerative and neuroinfectious diseases. Neurotherapeutics, 21(1), 112-128.
7.Naushad, W., Okeoma, B.C., Islam, H.K., Wang, Z.Z., Yang, N., Li, X., &Okeoma, C.M. (2024). Berberine: A dual anti-HIV and anti-cervical cancer compound. bioRxiv, 2024.01.15.575789.
8.Nebir, S.S., Arian, T.A., Sarkar, B., et al. (2025). Computational Evaluation of Phytochemicals as Potential Anti-HIV Drugs Targeting CCR5 and CXCR4 Receptors. Cold Spring Harbor Laboratory, 2025.03.01.640898.
9.Shinhasan, M.P., &Arumugam, D.M. (2026). A novel extraction and LC-MS/MS-QTOF based metabolite profiling coupled with ADMET and PASS server prediction unveils anti-HIV leads from Ocimumtenuiflorum L. International Journal of Pharmaceutical Sciences and Research, 17(2), 567-589.